Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:roflumilast
|
| gptkbp:approvedBy |
gptkb:FDA
2011 |
| gptkbp:ATCCode |
R03DX07
|
| gptkbp:contraindication |
severe liver impairment
|
| gptkbp:drugClass |
phosphodiesterase-4 inhibitor
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Daliresp
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:AstraZeneca
|
| gptkbp:mechanismOfAction |
inhibits phosphodiesterase-4
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
diarrhea headache weight loss insomnia |
| gptkbp:usedFor |
gptkb:COPD
chronic obstructive pulmonary disease |
| gptkbp:bfsParent |
gptkb:AstraZeneca_US
|
| gptkbp:bfsLayer |
6
|